Showing 941 - 960 results of 3,149 for search '"breast"', query time: 0.11s Refine Results
  1. 941

    Mutational Analysis of BRAFV600E by Polymerase Chain Reaction in Breast Cancer: A Narrative Review by Simran Khan, Arvind Bhake

    Published 2025-01-01
    “…A major cause of cancer-related death for women globally is breast cancer, calling for molecular insights to better prognosis and treatment. …”
    Get full text
    Article
  2. 942

    Breast decorations from the burials of the Bolshiye Pamyaly burial ground of the XVIII – first half of the XIX century by Voronov Vsevolod V.

    Published 2024-12-01
    “…The classification of sul’gams uses the method of considering them as parts of breast decorations, considered by T.B. Nikitina according to their functional purpose. …”
    Get full text
    Article
  3. 943
  4. 944
  5. 945
  6. 946
  7. 947

    Exploring the Social Media Discussion of Breast Cancer Treatment Choices: Quantitative Natural Language Processing Study by Daphna Y Spiegel, Isabel D Friesner, William Zhang, Travis Zack, Gianna Yan, Julia Willcox, Nicolas Prionas, Lisa Singer, Catherine Park, Julian C Hong

    Published 2025-01-01
    “… Abstract BackgroundEarly-stage breast cancer has the complex challenge of carrying a favorable prognosis with multiple treatment options, including breast-conserving surgery (BCS) or mastectomy. …”
    Get full text
    Article
  8. 948

    Impact of Paracoccus sp. EGY7 carotenoids on triple-negative breast cancer cells: invitro study by Karim Abdelazim, Ahmed Hussein, Sherine N. Khattab, Shaymaa Essam El Feky, Nehad Noby

    Published 2025-02-01
    “…EGY7 carotenoids on the triple-negative breast cancer cell line (MDA-MB-231). The bacterial strain was isolated, and its carotenoids profile was analyzed via HPLC-DAD-MS. …”
    Get full text
    Article
  9. 949
  10. 950

    Application of Synthetic Polymeric Scaffolds in Breast Cancer 3D Tissue Cultures and Animal Tumor Models by Girdhari Rijal, Chandra Bathula, Weimin Li

    Published 2017-01-01
    “…Estrogen receptor- (ER-) positive T47D breast cancer cells are less sensitive to 4-hydroxytamoxifen (4-HT) treatment when cultured on the 3D porous scaffolds than in 2D cultures. …”
    Get full text
    Article
  11. 951

    Breast Implant Illness May Be Rooted in Mast Cell Activation: A Case-Controlled Retrospective Analysis by Èva S. Nagy, BMedSci(Hons), MBBS, PhD, FRACS, Grad Cert (Breast Surgery), Mark Westaway, MBBS, DCH, Grad Dip Allergy, Suzanne Danieletto, BSc, MBBS (Hons), FRCPA, MIAC, Lawrence B. Afrin, MD

    Published 2024-03-01
    “…To investigate the possible association between breast implant illness (BII) and mast cell activation syndrome (MCAS), which often manifests increased mast cells (MCs) in assorted tissues and may explain BII symptoms. …”
    Get full text
    Article
  12. 952

    The Contribution of Three-Dimensional Power Doppler Imaging in the Preoperative Assessment of Breast Tumors: A Preliminary Report by K. Kalmantis, C. Dimitrakakis, Ch. Koumpis, A. Tsigginou, N. Papantoniou, S. Mesogitis, A. Antsaklis

    Published 2009-01-01
    “…Sonographic criteria used for breast cancer diagnosis were based on a system that included morphological characteristics and criteria of the vascular pattern of a breast mass by Power Doppler imaging. …”
    Get full text
    Article
  13. 953
  14. 954
  15. 955

    Chitosan-Based Nanogel Enhances Chemotherapeutic Efficacy of 10-Hydroxycamptothecin against Human Breast Cancer Cells by Hui Guo, Faping Li, Heping Qiu, Qi Zheng, Chao Yang, Chao Tang, Yuchuan Hou

    Published 2019-01-01
    “…In this work, a positively charged CS-based nanogel was designed and synthesized to inhibit the proliferation of breast cancer cell lines. The model drug of 10-hydroxycamptothecin (HCPT) was entrapped into the core via a facile diffusion to form CS/HCPT. …”
    Get full text
    Article
  16. 956
  17. 957
  18. 958
  19. 959
  20. 960

    Third Swiss Annual Meeting on HER2-Positive Breast Cancer: Recent Advances and New Challenges by Marcus Vetter, Christian Kurzeder

    Published 2024-09-01
    “…The development of antibody-based therapies has transformed the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. More recently, HER2-directed antibody-drug conjugates (ADCs) have demonstrated efficacy in HER2-negative breast cancer patients who had a certain level of HER2 expression (HER2 low). …”
    Get full text
    Article